CHC Healthcare Group (TPE:4164)

Market Cap	5.21B -32.6%
Revenue (ttm)	4.55B +15.2%
Net Income	204.07M +16.9%
EPS	1.05 +4.0%
Shares Out	195.31M
PE Ratio	25.41
Forward PE	n/a
Dividend	1.10 (4.09%)
Ex-Dividend Date	Jun 29, 2026

Volume	538,135
Open	27.30
Previous Close	26.90
Day's Range	26.70 - 27.50
52-Week Range	26.70 - 52.30
Beta	0.18
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 5, 2026

About CHC Healthcare Group

CHC Healthcare Group, together with its subsidiaries, trades in medical equipment, pharmaceutical products, and health food in Taiwan, China, and internationally. The company is also involved in the leasing, installing, servicing, and repairing of medical instruments for use in various specialties, such as radiation oncology, medical imaging, neurology, surgery, ophthalmology, robot rehabilitation, dentistry, and smart health care. In addition, it engages in the irradiation business; sale of daily necessities, beauty products, and health supple...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 2009
• Country: Taiwan
• Stock Exchange: Taiwan Stock Exchange
• Ticker Symbol: 4164

Financial Performance

In 2025, CHC Healthcare Group's revenue was 4.40 billion, an increase of 22.15% compared to the previous year's 3.60 billion. Earnings were 186.28 million, an increase of 10.63%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jul 20, 2026

Data Sources Report a data error